Fortress Biotech
FBIO
40 hedge funds and large institutions have $5.61M invested in Fortress Biotech in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 9 closing their positions.
254% more call options, than puts
Call options by funds: $163K | Put options by funds: $46K
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
5% less funds holding
Funds holding: 42 → 40 (-2)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
15.63% less ownership
Funds ownership: 31.58% → 15.95% (-16%)
60% less capital invested
Capital invested by funds: $14.1M → $5.61M (-$8.48M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$322K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$250K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$213K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$117K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$113K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2.3M |
| 2 |
AC
Armistice Capital
New York
|
-$1.79M |
| 3 |
ACM
Altium Capital Management
New York
|
-$1.22M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$985K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$188K |
FBIO Hedge Fund Activity: Q1 2024 in Review
40 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2024, worth a combined $5.61M — down 60% from $14.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of FBIO and 8 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 13 added.
The largest buyer was Acadian Asset Management, adding an estimated $322K. The largest seller was CVI Holdings, exiting entirely with an estimated $2.3M sold.
- 40 institutional investors held Fortress Biotech (FBIO) as of Q1 2024, down from 42 in Q4 2023.
- Funds reported $5.61M of Fortress Biotech stock for Q1 2024, down 60% quarter-over-quarter.
- 8 funds opened new Fortress Biotech positions in Q1 2024 and 9 closed out, a net change of -1 holder.
- The largest Fortress Biotech buyer in Q1 2024 was Acadian Asset Management, an estimated $322K added.
- The largest Fortress Biotech seller in Q1 2024 was CVI Holdings, an estimated $2.3M sold.
Based on aggregated 13F filings for Q1 2024.